{"public_id":"cl_51869ff56362798e2bcd66c60260ef31","status":"active","superseded_by_public_id":null,"corpus_id":36343021,"text":"WHO subgroups, karyotype, and transfusion requirement are the most important variables for the prognostic model in myelodysplastic syndromes.","confidence":0.95,"paper":{"corpus_id":36343021,"title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.","url":"https://sah.borca.ai/papers/36343021"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_5ceb8c29afeb1cd926e5d1a85372758f","name":"WHO subgroups","description":"The World Health Organization classification subgroups used to categorize myelodysplastic syndromes patients.","types":["classification"],"url":"https://sah.borca.ai/concepts/co_5ceb8c29afeb1cd926e5d1a85372758f"},{"public_id":"co_6757cc81a4ce21b8e2a92f0ed3bd8394","name":"transfusion requirement","description":"Whether a patient requires blood transfusions, used as a time-dependent prognostic variable.","types":["clinical feature"],"url":"https://sah.borca.ai/concepts/co_6757cc81a4ce21b8e2a92f0ed3bd8394"},{"public_id":"co_ab8746738098166efae3d4c16ea8263d","name":"karyotype","description":"The chromosomal characteristics of MDS patients, used as a prognostic factor in the model.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_ab8746738098166efae3d4c16ea8263d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_51869ff56362798e2bcd66c60260ef31"}